Yusuke Narita

469 total citations
29 papers, 353 citations indexed

About

Yusuke Narita is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yusuke Narita has authored 29 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Yusuke Narita's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yusuke Narita is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yusuke Narita collaborates with scholars based in Japan, United States and Australia. Yusuke Narita's co-authors include Ryo Nishikawa, Yasuji Miyakita, Hiroyuki Momota, Soichiro Shibui, Joji Mima, Rikimaru Hayashi, Shingo Takano, Yoshihiro Muragaki, Motoo Nagane and J. Kuratsu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Molecular Biology.

In The Last Decade

Yusuke Narita

28 papers receiving 344 citations

Peers

Countries citing papers authored by Yusuke Narita

Since Specialization

Citations

This map shows the geographic impact of Yusuke Narita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Narita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Narita more than expected).

Fields of papers citing papers by Yusuke Narita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Narita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Narita. The network helps show where Yusuke Narita may publish in the future.

Co-authorship network of co-authors of Yusuke Narita

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Narita. A scholar is included among the top collaborators of Yusuke Narita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Narita. Yusuke Narita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical evaluation of a fully automated and high-throughput molecular testing system for detection of influenza virus 2022 ·Virology Journal ·Kosuke Kosai, Norihito Kaku, (unknown), (unknown), Norihiko Akamatsu, Yusuke Narita, Yasushi Matsumoto, (unknown), Yohei Mizuta, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara	3
2	Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness 2021 ·Journal of Infection and Chemotherapy ·Norihito Kaku, (unknown), Norihiko Akamatsu, (unknown), Kosuke Kosai, Yoshitomo Morinaga, Yusuke Narita, Yasushi Matsumoto, (unknown), Yohei Mizuta, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara	5
3	Use of mycophenolate mofetil for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database 2021 ·Modern Rheumatology ·Takashi Funatogawa, Yusuke Narita, (unknown), (unknown), (unknown), (unknown)	2
4	[Successful treatment of post-allogeneic hematopoietic transplant immune thrombocytopenia with eltrombopag]. 2019 ·PubMed ·Yusuke Narita, (unknown), Chisaki Mizumoto, Tomoharu Takeoka, (unknown), (unknown), Tatsuharu Ohno	2
5	Safety, efficacy, PK and PD biomarker results of the first-in-human study of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor BAY 1436032 in patients (pts) with mIDH1 advanced solid tumours 2019 ·Annals of Oncology ·Wolfgang Wick, Ghazaleh Tabatabai, Martin Schüler, (unknown), Sant P. Chawla, Filip Jankú, David Schiff, Volker Heinemann, Yusuke Narita, Yuichi Ando, Heinz‐Josef Lenz, Masafumi Ikeda, Isabelle Genvresse, Christine Rentzsch, (unknown), (unknown), Carolyn Cai, Michael Jeffers, Carol E. Peña, Oliver Bähr	2
6	146P Tolerability and pharmacokinetics (PK) of ABT-414 in Japanese patients (pts) with recurrent malignant glioma 2016 ·Annals of Oncology ·Yusuke Narita, Motoo Nagane, Naoki Kagawa, Kazuhiko Mishima, Tetsuya Yamamoto, Toshihiko Wakabayashi, Takashi Hamada, (unknown), (unknown), (unknown), Xiong, Clara B. Ocampo, Ryo Nishikawa	1
7	Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer 2015 ·Lung Cancer ·Yusuke Narita, (unknown), Takeru Shiroiwa, Kōji Chiba, Yoichi Nakanishi, (unknown), Hisashi Urushihara	31
8	Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing 2015 ·Carcinogenesis ·Reika Iwakawa, Takashi Kohno, Yasushi Totoki, Tatsuhiro Shibata, (unknown), Sachiyo Mimaki, K. Tsuta, Yusuke Narita, Ryo Nishikawa, Masayuki Noguchi, Curtis C. Harris, Ana I. Robles, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Hirohiko Totsuka, Teruhiko Yoshida, Jun Yokota	64
9	Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model 2014 ·Molecular Cancer Therapeutics ·Yusuke Narita, Kiyoshi Okamoto, (unknown), Kazuma Takase, Yukinori Minoshima, Kotaro Kodama, Masao Iwata, Norimasa Miyamoto, Kohei Sawada	23
10	INCIDENCE AND OUTCOMES IN GLIOMAS FROM BRAIN TUMOR REGISTRY OF JAPAN 2001-2004 2014 ·Neuro-Oncology ·Yusuke Narita, Soichiro Shibui	0
11	Concurrent Subcutaneous Candidal Abscesses and Pulmonary Cryptococcosis in a Patient with Diabetes Mellitus and a History of Corticosteroid Therapy 2014 ·Internal Medicine ·Hiroshi Kakeya, Koichi Izumikawa, Koichi Yamada, Yusuke Narita, Tomoya Nishino, Yoko Obata, Takahiro Takazono, Shintaro Kurihara, Kosuke Kosai, Yoshitomo Morinaga, Shigeki Nakamura, Yoshifumi Imamura, Taiga Miyazaki, Misuzu Tsukamoto, Katsunori Yanagihara, Motoi Takenaka, Takayoshi Tashiro, Shigeru Kohno	8
12	Secondary hematological malignancies associated with temozolomide in patients with glioma 2013 ·Neuro-Oncology ·Hiroyuki Momota, Yusuke Narita, Yasuji Miyakita, Soichiro Shibui	34
13	Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma 2012 ·Japanese Journal of Clinical Oncology ·Motoo Nagane, Ryo Nishikawa, Yusuke Narita, H. Kobayashi, Shingo Takano, Nobusada Shinoura, Taku Aoki, Keiji Sugiyama, J. Kuratsu, Yoshihiro Muragaki, (unknown), (unknown)	70
14	[A case of Wegener's granulomatosis with seronegative for PR-3 ANCA and seropositive for MPO-ANCA]. 2009 ·PubMed ·Yusuke Narita, Tetsuo Yamaguchi, Kensuke Tanaka, Hirokazu Urushiyama, (unknown), (unknown), Yoshihito Yamada, (unknown), Tamiko Takemura	1
15	[Case of bilateral chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant-resistant pleural effusion]. 2008 ·PubMed ·Yusuke Narita, (unknown), Naoya Hida, Hiroaki Okamoto, Hiroshi Kunikane, (unknown), (unknown), Koshiro Watanabe	1
16	[A case of legionella pneumonia associated with acute respiratory distress syndrome (ARDS) and acute renal failure treated with methylprednisolone and sivelestat]. 2007 ·PubMed ·Yusuke Narita, (unknown), (unknown), Naoya Hida, Hiroaki Okamoto, Hiroshi Kunikane, Koshiro Watanabe	8
17	A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer 2006 ·Lung Cancer ·Hiroaki Okamoto, Katsuhiko Naoki, Yusuke Narita, Naoya Hida, Hiroshi Kunikane, Koshiro Watanabe	18
18	Structure of the Carboxypeptidase Y Inhibitor IC in Complex with the Cognate Proteinase Reveals a Novel Mode of the Proteinase–Protein Inhibitor Interaction 2005 ·Journal of Molecular Biology ·Joji Mima, (unknown), Tomomi Fujii, Yusuke Narita, Rikimaru Hayashi, Mitsuyoshi Ueda, Yasuo Hata	29
19	The Multiple Site Binding of Carboxypeptidase Y Inhibitor (IC) to the Cognate Proteinase 2003 ·Journal of Biological Chemistry ·Joji Mima, Yusuke Narita, Hiroaki Chiba, Rikimaru Hayashi	15
20	Development of an automated measurement system using a diffusion scrubber and high-performance liquid chromatography for the monitoring of formaldehyde and acetaldehyde in automotive exhaust gas 1998 ·The Analyst ·Y. Komazaki, Yusuke Narita, Shigeru Tanaka	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact